CrowdPharm Profiled In MM+M Agency 100 Report


Medical Marketing + Media launches the 2022 Agency 100, a list of the top agencies in medical marketing and communications

KANSAS CITY, MO – JUNE 7, 2022 – CrowdPharm, a full-service agency with the largest network of global talent in healthcare, has been named to the Medical Marketing + Media 2022 Agency 100 list. The publication annually ranks North America’s top 100 medical marketing and communication agencies. The June issue includes profiles of the top 100 ranked agencies and highlights Ones to Watch. In 2021, MM+M selected CrowdPharm as one of the nine Ones to Watch agencies, a special category within the Agency 100 issue highlighting star-making strong performances.

“We are proud to be recognized as a top 100 agency this year. This recognition is a reflection of our amazing team and our partner clients,” said Mike Myers, Managing Director and Partner. “Congratulations to all the agencies included in the 2022 MM+M Agency 100.”

CrowdPharm is a full-service agency offering something no one else in healthcare marketing has provided to clients and brands before—a full-time team directly connected with 4,900+ global specialists across 100+ countries. The agency’s unique approach offers the consistency and dedication brands require, turbocharged with access to one of the largest global healthcare talent pools ever created. Through hard work and proprietary technology, CrowdPharm’s full-time industry veterans created a network of vetted on-demand healthcare talent, which allows them to customize teams scaled to client needs, keep work moving around the globe, and provide flexible and cost-effective solutions. Different by design, CrowdPharm delivers compelling brand communications in healthcare, medical, and pharmaceutical marketing.

“This year’s Agency 100 issue showcases the continued broadening of the agency world’s offerings—deeper into data, AI, user experience and more—as well as the ingenuity companies displayed in virtualizing their business amid the COVID-19 pandemic,” said MM+M GM Steve Madden. “You’ll see how agencies have moved to distinguish and differentiate themselves in a crowded landscape, producing great work under challenging circumstances. It’s an amazing and unprecedented time for the business.” MM+M’s annual breakdown of the Agency 100 survey data reveals a host of trends, challenges, and opportunities.

About CrowdPharm
CrowdPharm is a full-service agency led by industry veterans and fueled by the largest network of global healthcare talent anywhere. Innovative technology enables the agency to deliver an abundance of original strategic and creative solutions and provide a flexible force of talent with experience that spans startups, orphan products, blockbusters, and primary care. With 4,900+ members across 100+ countries, the agency is ready to develop compelling brand communications in healthcare, medical, and pharmaceutical marketing for pharmaceutical and biopharma companies. Visit

MM+M is the media brand of record for pharmaceutical marketing and commercialization, delivering the most balanced and relevant coverage of its subject matter. The 55-year-old business title produces online breaking news and analysis as well as in-depth print features for an audience of pharma, device, diagnostics and greater healthcare marketing leaders and thinkers. Working in tandem with Haymarket Media’s events division, MM+M develops annual conferences and live and virtual events. It also runs the industry’s premier awards program—the MM+M Awards, which celebrates creativity and effectiveness in healthcare marketing. Visit

For more information, contact:
Lori Goodale
VP, Director of Marketing and Corporate Communications

More posts
New Artist-Protecting Technology Helps Fight Against Copyright Violation
Read more >
CrowdPharm's Work in AI Is Named by PM360 as One of the Most Interesting Innovations of 2023
Read more >
CrowdPharm Named MM+M Best Places to Work 2023
Read more >
See more